Kingworld Medicines Group Limited (01110) released its monthly return for the period ended 31 October 2025. The authorized share capital remains at 10,000,000,000 ordinary shares, each with a par value of HKD 0.1, totaling HKD 1,000,000,000. No increase or decrease was recorded during the month.

The number of issued shares stood at 622,500,000, with no reported movement in treasury shares. There were no share options, warrants, convertibles, or other arrangements to issue additional shares for the period under review.